Directa Plus PLC (LON:DCTA) said research has been published supporting the use of its ‘functionalised’ graphene as an antimicrobial in face masks.
The peer-reviewed paper, which appeared in the journal iScience, said the company's G+ nanomaterials and those from graphene oxide provide a “critical opportunity to significantly increase face mask efficacy”.
Directa said to date it has treated and supplied more than 240,000 meters of G+ graphene fabrics and produced and delivered more than one million G+ filters to fight the COVID-19 pandemic.